Study of neuroblastoma patients’ experience over time
Part of Cancer clinical trials.
This study looks at patterns in what adults with neuroblastoma experience during treatment and follow-up visits. It may help researchers understand what patients go through so care and support can improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of neuroblastoma
- You are 18 years or older and can sign written consent
- You’re able and willing to follow the study schedule, including visits and treatment while enrolled
- If you can become pregnant, you must have a negative pregnancy test before joining, and you cannot be breastfeeding
- You cannot join if you have another serious, unstable health problem that could interfere with the study
- You cannot be enrolled in another research study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how high-risk neuroblastoma grows and behaves by collecting samples from your child and checking disease markers. It may help researchers understand what biology is driving the cancer and guide future treatments.
This Phase 3 trial tests treatments for children and teens with high-risk neuroblastoma, aiming to improve outcomes by using biology-based risk information. It also requires limited prior chemotherapy and specific timing after diagnosis.
This study collects blood samples from neuroblastoma patients to test for tiny pieces of tumor DNA that can show how well treatment is working. By tracking these markers over time, doctors hope to better predict how patients will respond and improve care.
This study creates an international registry linked to a virtual biobank, so researchers can collect and share information and biological samples for patients with specific peripheral neuroblastic tumors. It may help future research and care planning by improving what scientists know about these conditions.
This trial tests giving a combination of naxitamab, irinotecan, and temozolomide for a longer period to people whose neuroblastoma has come back or hasn't responded to standard treatments. The goal is to see if this approach is safe and effective.
This Phase 2 trial studies a targeted treatment approach for children and young adults with advanced neuroblastoma (a childhood cancer). It may help by using lab-tested cancer features to guide therapy after initial treatment and transplant.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.